An innovative program pairs genetic testing with personalized lifelong cancer prevention

NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.
Morningstar

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical ...
AOL

Genetic testing IDs some at higher risk for colorectal cancer

DUPAGE COUNTY, Ill. (WGN) — It’s a quiet day in Wheaton, and Jessica Wozniak is in her kitchen, making a cup of tea. The mother of a preschooler is taking advantage of some time to relax, read, and ...
Healio

Genetic testing helps to identify those at risk for colorectal cancer

So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...
Medical Xpress

DNA testing of colorectal polyps improves insight into hereditary risks

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients. Research from Radboud University Medical Center and University Hospital Bonn (UKB ...
ascopubs.org

Diagnostic yield of germline genetic testing for early-onset colorectal cancer in a safety-net healthcare system.

An update on the impact of COVID-19 on colorectal cancer screening using Medicare claims data. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This abstract ...
Nature

Genetic Testing Strategies for Lynch Syndrome in Colorectal Cancer

The diagnosis of Lynch syndrome in patients with colorectal cancer has evolved from reliance on clinical criteria to integrated molecular and genetic approaches. Genetic testing strategies typically ...

Myriad Genetics, Inc.: Myriad Genetics Expands Availability of Precise MRD for Colorectal, Renal and Breast Cancers, Supported by New Publication

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise ...
Chicago Tribune

Wenora Johnson: Early cancer detection, with new tools and genetic testing, saves lives

After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal cell carcinoma, I know just how crucial early detection can be in saving ...
mskcc.org

Bring these questions to your next appointment

When you learn you have colon cancer, you’ll probably have many questions to ask your cancer doctor at your first visit. Talking about treatment options with your doctor can help you feel better ...
Nature

Germline pathogenic variant spectrum and prevalence among colorectal cancer patients undergoing multigene panel testing in Kazakhstan

Colorectal cancer (CRC) is the second most common malignancy in the Republic of Kazakhstan, accounting for 10.6% of all cancer cases, after breast cancer (14.9%), lung cancer (10.5%), and stomach ...